EU wants more transparency on AbbVie's Humira, world's top drug

LONDON (Reuters) - Details of clinical trials involving AbbVie's rheumatoid arthritis drug Humira, the world's top-selling prescription medicine, are still being withheld without justification, according to the European Union's ombudsman.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news